Samuel Santiago Name match only — unverified
Consultant · activity score 135
$286,824
paid as individual · 1 payer
5y
activity span (2022-2026)
Activity over time 5 year span
Committee-officer role
Candidate filing
IND-paid disbursement
Top payers 1 committee · $286,824 total
| Committee | Payments | Total |
|---|---|---|
| ACTBLUE | 139 | $286,824 |
Aggregated across all Schedule B IND payments to this name. Color: derived partisan lean of the paying committee (direct party_affiliation OR committee_partisan_lean.lean_score for super PACs).
Recent payments to this name last 20 · $31,633
| Date | Payer | Purpose | Amount |
|---|---|---|---|
| Jan 16, 2026 | ACTBLUE | PER DIEM | $215 |
| Dec 30, 2025 | ACTBLUE | SEE VILCHEZ SANTIAGO 12/30 MEMO ENTRIES | $180 |
| Dec 4, 2025 | ACTBLUE | PER DIEM | $215 |
| Sep 30, 2025 | ACTBLUE | SEE VILCHEZ SANTIAGO 09/30 MEMO ENTRIES | $111 |
| Sep 30, 2025 | ACTBLUE | PER DIEM | $387 |
| Jun 30, 2025 | ACTBLUE | GROUND TRANSPORTATION | $293 |
| Jun 30, 2025 | ACTBLUE | SEE VILCHEZ SANTIAGO 06/30 MEMO ENTRIES | $653 |
| Jun 20, 2025 | ACTBLUE | SALARY | $3,247 |
| Jun 6, 2025 | ACTBLUE | SALARY | $3,147 |
| May 23, 2025 | ACTBLUE | SALARY | $3,247 |
| May 9, 2025 | ACTBLUE | SALARY | $3,147 |
| Apr 25, 2025 | ACTBLUE | SALARY | $3,247 |
| Apr 11, 2025 | ACTBLUE | SALARY | $3,051 |
| Apr 7, 2025 | ACTBLUE | SEE VILCHEZ SANTIAGO 04/07 MEMO ENTRIES | $500 |
| Mar 31, 2025 | ACTBLUE | SALARY | $8 |
| Mar 28, 2025 | ACTBLUE | SALARY | $3,143 |
| Mar 25, 2025 | ACTBLUE | PER DIEM | $301 |
| Mar 14, 2025 | ACTBLUE | SALARY | $3,051 |
| Mar 6, 2025 | ACTBLUE | SEE VILCHEZ SANTIAGO 03/06 MEMO ENTRIES | $425 |
| Feb 28, 2025 | ACTBLUE | SALARY | $3,065 |
Disbursement rows where this name appears as the payee (schedule_b entity_tp='IND'). Name-matched, not identity-resolved — may include same-named individuals.
Geographic concentration 1 state
MA
1 payer cmte
Composite of candidate filings (cand.state) + states of distinct payer committees. Surfaces where the operative is geographically active.